All Pharma News
BMS gains EMA validation for Opdivo/Yervoy combo in liver cancer

BMS gains EMA validation for Opdivo/Yervoy combo in liver cancer
PRESS RELEASE
20 Jul 2024
Share Share
Aveo`s Fotivda fail as combo in kidney cancer

Aveo`s Fotivda fail as combo in kidney cancer
FIERCE PHARMA
19 Jul 2024
Share Share
Bristol Myers Squibb Reaches Major Milestone in Environmental Sustainability

Bristol Myers Squibb Reaches Major Milestone in Environmental Sustainability
ACCESSWIRE
18 Jul 2024
Share Share
J&J, BMS and AZ appeal IRA litigation losses

J&J, BMS and AZ appeal IRA litigation losses
FIERCE PHARMA
16 Jul 2024
Share Share
Bristol Myers’ leukemia blockbuster set to face generic rivals

Bristol Myers’ leukemia blockbuster set to face generic rivals
Amy Baxter BIOPHARMADIVE
13 Jul 2024
Share Share
Abecma competition, Sotyktu pricing pressure and IRA: Analysts outline BMS

Abecma competition, Sotyktu pricing pressure and IRA: Analysts outline BMS
FIERCE PHARMA
12 Jul 2024
Share Share
Bristol Myers Squibb To Join UBS Virtual Protein Degradation Day

Bristol Myers Squibb To Join UBS Virtual Protein Degradation Day
BUSINESSWIRE
08 Jul 2024
Share Share
LOTTE BIOLOGICS Holds Groundbreaking for Songdo Bio Campus

LOTTE BIOLOGICS Holds Groundbreaking for Songdo Bio Campus
PR NEWSWIRE
03 Jul 2024
Share Share
Japan`s Eisai terminates ADC manufacturing pact with BMS

Japan`s Eisai terminates ADC manufacturing pact with BMS
BIOSPECTRUM ASIA
03 Jul 2024
Share Share
BMS axes Eisai ADC pact 3 years after paying $650M for would-be Elahere rival

BMS axes Eisai ADC pact 3 years after paying $650M for would-be Elahere rival
Nick Paul Taylor FIERCE BIOTECH
02 Jul 2024
Share Share